Chemoinformaics analysis of N-Alpha-Acetyl-L-Arginine
Molecular Weight | 216.241 | nRot | 6 |
Heavy Atom Molecular Weight | 200.113 | nRig | 3 |
Exact Molecular Weight | 216.122 | nRing | 0 |
Solubility: LogS | -0.962 | nHRing | 0 |
Solubility: LogP | -2.085 | No. of Aliphatic Rings | 0 |
Acid Count | 1 | No. of Aromatic Rings | 0 |
Base Count | 3 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 4 | No. of Arom Atom | 0 |
No. of Oxygen atom | 3 | No. of Arom Bond | 0 |
nHA | 3 | APOL | 30.8347 |
nHD | 4 | BPOL | 18.3573 |
QED | 0.247 |
Synth | 2.597 |
Natural Product Likeliness | 0.956 |
NR-PPAR-gamma | 0.003 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.005 |
Pgp-sub | 0.984 |
HIA | 0.013 |
CACO-2 | -6.253 |
MDCK | 0.00179795 |
BBB | 0.803 |
PPB | 0.0763533 |
VDSS | 0.45 |
FU | 0.87787 |
CYP1A2-inh | 0.003 |
CYP1A2-sub | 0.047 |
CYP2c19-inh | 0.017 |
CYP2c19-sub | 0.047 |
CYP2c9-inh | 0.005 |
CYP2c9-sub | 0.026 |
CYP2d6-inh | 0.009 |
CYP2d6-sub | 0.18 |
CYP3a4-inh | 0.004 |
CYP3a4-sub | 0.011 |
CL | 2.452 |
T12 | 0.292 |
hERG | 0.083 |
Ames | 0.009 |
ROA | 0.019 |
SkinSen | 0.275 |
Carcinogencity | 0.074 |
EI | 0.031 |
Respiratory | 0.039 |
NR-Aromatase | 0.002 |
Antiviral | No |
Prediction | 0.873644 |